Enteropathy-associated T-cell lymphoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) (Created page with "===Laboratory Findings=== *Laboratory tests for enteropathy-associated T-cell lymphoma include:<ref name="cancer.gov">Enteropathy-associated T-cell lymphoma. Surveillance, Epi...") |
Nima Nasiri (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
**[[Immunohistochemistry]] | **[[Immunohistochemistry]] | ||
**[[Immunophenotyping]]: [[CD3]]+, [[CD4]]-, [[CD5]]-, [[CD7]]+, [[CD30]]+, [[CD56]]+, [[CD103]]+, [[CD8]]+/-, and TCR beta+/- | **[[Immunophenotyping]]: [[CD3]]+, [[CD4]]-, [[CD5]]-, [[CD7]]+, [[CD30]]+, [[CD56]]+, [[CD103]]+, [[CD8]]+/-, and TCR beta+/- | ||
==References== | |||
{{reflist|2}} | |||
Revision as of 17:56, 9 January 2019
Laboratory Findings
- Laboratory tests for enteropathy-associated T-cell lymphoma include:[1]
- Complete blood count (CBC)
- Blood chemistry studies
- Cytogenetic analysis
- Flow cytometry
- Immunohistochemistry
- Immunophenotyping: CD3+, CD4-, CD5-, CD7+, CD30+, CD56+, CD103+, CD8+/-, and TCR beta+/-
References
- ↑ Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 26, 2016